Tadalafil Tablet, Film Coated
Product Images NDC 50090-7391

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 50090-7391). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907391)

Tadalafil 5 mg film-coated tablets packaged by A-S Medication Solutions. The label shows the product name, dosage strength, lot number, storage temperature instructions (68-77°F), and quantity of 90 tablets. It includes a QR code and NDC 50090-7391 for identification.*

FDA Label Image

Spl-tadalafil-figure-1 (Spl Tadalafil Figure 1)

A set of four line graphs displaying the difference in blood pressure measurements (Tadalafil minus placebo) over time in hours. The graphs show standing systolic BP, standing diastolic BP, supine systolic BP, and supine diastolic BP, each with error bars indicating variability.*

FDA Label Image

Spl-tadalafil-figure-2 (Spl Tadalafil Figure 2)

Two line graphs depicting systolic blood pressure changes (mmHg) over 24 hours post-dose. The top graph shows standing systolic blood pressure, comparing Tadalafil 20 mg with doxazosin 8 mg versus placebo with doxazosin 8 mg. The bottom graph shows supine systolic blood pressure for the same treatment groups. Both graphs plot time post-dose in hours (x-axis) against blood pressure change (y-axis).*

FDA Label Image

Spl-tadalafil-figure-3 (Spl Tadalafil Figure 3)

A line graph showing the effect on systolic blood pressure (mmHg) over 12 hours following administration of 20 mg tadalafil or placebo combined with 8 mg doxazosin. The graph compares blood pressure changes at dosing times 08:00 and 20:00, displaying four distinct data series with values fluctuating around baseline (0 mmHg).*

FDA Label Image

Spl-tadalafil-figure-4 (Spl Tadalafil Figure 4)

A line graph showing plasma tadalafil concentration (µg/L) over time (hours). It compares three conditions: a single 20-mg tadalafil dose, a single 5-mg tadalafil dose, and once-daily 5-mg tadalafil after five consecutive days. The y-axis represents plasma concentration from 0 to 500 µg/L, and the x-axis spans 0 to 120 hours, with error bars indicating variability.*

FDA Label Image

Spl-tadalafil-figure-5 (Spl Tadalafil Figure 5)

A line graph comparing the change from baseline in IPSS total score over 12 weeks of treatment between Tadalafil 5 mg and placebo. The x-axis shows duration of treatment in weeks (0, 4, 8, 12), and the y-axis represents change from baseline in IPSS total score, ranging from 0 to -6. Two lines depict the scores: a solid line with circles for Tadalafil 5 mg showing a greater decrease, and a dashed line with triangles for placebo showing a smaller decrease. Statistical significance at 12 weeks is marked with an asterisk (p < 0.01).*

FDA Label Image

Spl-tadalafil-figure-6 (Spl Tadalafil Figure 6)

A line graph depicting the change from baseline in IPSS Total Score over 12 weeks of treatment, comparing Tadalafil 5 mg and placebo. The x-axis indicates treatment duration in weeks, and the y-axis shows the score change. Tadalafil shows a greater decrease in score than placebo, with statistical significance noted at weeks 4 and 12.*

FDA Label Image

Spl-tadalafil-figure-8 (Spl Tadalafil Figure 8)

A line graph depicting the change from baseline in IPSS Total Score over 12 weeks of treatment. Two groups are compared: Tadalafil 5 mg (solid line with filled circles) and Placebo (dashed line with open triangles). The graph shows greater reduction in score over time with Tadalafil 5 mg than with placebo, with a significant difference indicated at 12 weeks.*

FDA Label Image

Spl-tadalafil-structure (Spl Tadalafil Structure)

Chemical structure of Tadalafil showing its molecular arrangement including fused rings, nitrogen, oxygen atoms, and methyl groups, consistent with the active ingredient Tadalafil in the provided product data.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.